Caralluma fimbriata
Caralluma fimbriata, commonly known as the desert succulent, is a remarkable medicinal plant native to arid regions of India. Renowned for its unique phytochemical properties, it is traditionally utilized for its potential anti-obesity effects, appetite suppression, and metabolic benefits, offering significant interest in modern pharmacological research and wellness.
- Scientific name: Caralluma fimbriata
- Family: Apocynaceae
- Native range: Asia-Tropical
Taxonomical Classification
This plant, Caralluma fimbriata, belongs to the kingdom Plantae and the phylum Streptophyta. It is classified under the class Equisetopsida and the subclass Magnoliidae, falling within the order Gentianales. Ultimately, it is a member of the family Apocynaceae and the genus Caralluma.
| Rank | Classification | Source |
|---|---|---|
| Kingdom | Plantae | WCVP |
| Phylum | Streptophyta | WCVP |
| Class | Equisetopsida | WCVP |
| Subclass | Magnoliidae | WCVP |
| Order | Gentianales | WCVP |
| Family | Apocynaceae | WCVP |
| Genus | Caralluma | WCVP |
Common Names
This plant, Caralluma fimbriata, is known by the common name Resasta karaluma in Sinhala.| Language | Common Name | Source |
|---|---|---|
| sl | Resasta karaluma | Wikidata |
Distribution
This plant is distributed across specific regions within the Asian continent. Within the Indian Subcontinent, it can be found growing in India. It is also native to the island nation of Sri Lanka. Moving further east, the species extends into the Indo-China region. Specifically, its range includes the country of Myanmar.
| Region | Area | Source |
|---|---|---|
| Indian Subcontinent | India | WCVP |
| Indian Subcontinent | Sri Lanka | WCVP |
| Indo-China | Myanmar | WCVP |
Plant Parts
This plant, Caralluma fimbriata, is a succulent species where various components are utilized for their therapeutic properties. In traditional medicinal practices, the whole plants are often employed to harness the full spectrum of bioactive compounds present throughout the organism. Additionally, the leaves serve as a significant part of the plant, containing specific phytochemicals that contribute to its overall medicinal potency.- Total parts
- 2
- Scientific sources
- 2
| Plant Part | Sources | Confidence |
|---|---|---|
| whole plants | 1 | ★☆☆☆☆ |
| leaves | 1 | ★☆☆☆☆ |
Chemicals
Caralluma fimbriata has 3 reported phytochemicals identified across 3 scientific publications and several other databases. The most consistently reported chemicals include flavonoids, glycosides, tannins.
- Total chemicals
- 3
- Scientific sources
- 3
Most Reported Compounds
| Compound | Sources | Confidence |
|---|---|---|
| flavonoids | 1 | ★☆☆☆☆ |
| glycosides | 1 | ★☆☆☆☆ |
| tannins | 1 | ★☆☆☆☆ |
Activities
Caralluma fimbriata has 4 reported activities identified across 4 scientific publications and several other databases. The most consistently reported activities include Anticancer, Antioxidant, Hepatoprotective, Hypolipidemic.
- Total activities
- 4
- Scientific sources
- 4
Most Reported Activities
| Activity | Sources | Confidence |
|---|---|---|
| Anticancer | 1 | ★☆☆☆☆ |
| Antioxidant | 1 | ★☆☆☆☆ |
| Hepatoprotective | 1 | ★☆☆☆☆ |
| Hypolipidemic | 1 | ★☆☆☆☆ |
Medicinal Uses
Caralluma fimbriata has 10 reported medicinal uses identified across 10 scientific publications and several other databases. The most consistently reported uses include Metabolic Syndrome, VLDL-cholesterol, appetite, arthritis, cardiovascular diseases.
- Total uses
- 10
- Scientific sources
- 10
Most Reported Uses
| Use | Sources | Confidence |
|---|---|---|
| Metabolic Syndrome | 1 | ★☆☆☆☆ |
| VLDL-cholesterol | 1 | ★☆☆☆☆ |
| appetite | 1 | ★☆☆☆☆ |
| arthritis | 1 | ★☆☆☆☆ |
| cardiovascular diseases | 1 | ★☆☆☆☆ |
| high blood pressure | 1 | ★☆☆☆☆ |
| insulin resistance | 1 | ★☆☆☆☆ |
| metabolic syndrome | 1 | ★☆☆☆☆ |
| obesity | 1 | ★☆☆☆☆ |
| visceral obesity | 1 | ★☆☆☆☆ |